Regulatory watch
FDA’s 2026 review table: what it says about fluorinated HDPE
A dated “review of information” entry is an important but limited status statement.
THE ARCHIVE
Author: inhancetechn
Regulation
Why a production phase-out is not the same as a universal PFAS ban
Broad claims about “forever chemicals” need to identify the substance, use and operative action.
Environment watch
From container wall to waste stream: questions the Inhance file leaves open
Migration evidence is one stage of a broader materials pathway.
Environmental reporting
PFAS persistence and the risk of writing a personal diagnosis into a headline
General health concerns do not establish that one company caused a named person’s illness.
Exposure pathways
What a water sample could establish in a packaging investigation
A result needs context before it can support a claim about a source.
Visual evidence
A river photograph cannot prove an Inhance pollution claim
Why the source and location of an image matter as much as its emotional force.
Environment watch
Inhance, pesticide containers and the route by which PFAS entered the story
The original packaging investigation should not be confused with a survey of all pesticides.
Leadership
Prakash Iyer and Inhance Technologies: follow the evidence pathway
Why an executive’s name should lead readers toward documents, not unsupported personal claims.
Uncategorised
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!